Dotmatics

Dotmatics Resources for SLAS2023

Dotmatics provides comprehensive R&D scientific software solutions showcased at SLAS2023, including an overview of their platform, the Prism integration for enhanced data visualization and analysis, and specialized resources for biologics and small molecule discovery, with options to download content, speak with product experts, and request demos.

Content Showcase

Dotmatics Resources for SLAS2023

View some of our premium content to learn about the Dotmatics platform and other solutions from subject matter experts.

Table of contents

Download, watch and save some of the premium content we share at SLAS2023.

What is Dotmatics?

Dotmatics is the global leader in R&D scientific software that connects science, data, and decision-making. Combining a workflow and data platform with best-of-breed applications, we offer the first true end-to-end solutions for biology, chemistry, formulations, data management, flow cytometry, and more.

Download: Overview of Dotmatics

Prism by Dotmatics

Prism Integration: Templated Export of Dotmatics Data into Prism

Watch the Prism integration in action, so you can see first-hand how the connection would accelerate your research and expand your visualization and analysis capabilities.

Templated Export of Dotmatics Data into Prism

Press O for more options

Video Thumbnail

Video Thumbnail

Click for sound

3:57

Download our Prism Integration resources to uncover the features, benefits and answers to frequently asked questions about the integration.

Download: The Prism Integration Overview

Download: The Prism Integration FAQ

The GraphPad Prism Solution

Learn how you can achieve enhanced analysis and visualization for your scientific research with GraphPad Prism.

Download: The GraphPad Prism Solution

Biologics Discovery Resources

The Dotmatics Biology Solution provides end-to-end data management and analysis capabilities that fit into your established research and development workflow.

Download Overview: Biology Enterprise Solution

The pressure to innovate in biologics discovery is extraordinarily high. In our eBook, you will learn how to overcome this pressure with modern solutions to improve access to novel therapies.

Download eBook: Optimizing Biologics Discovery

Small Molecule Discovery Resources

With rising pressure to do more with less, companies need to adopt processes and technologies that will help them drive innovation while controlling costs.

Download Overview: Small Molecule Discovery Solution Overview

In this eBook, learn how to address common challenges in small molecule drug discovery so you can ensure data is trustworthy and traceable, improve productivity and collaboration, speed up research, and reduce technical debt and total cost of ownership.

Download eBook: Optimizing Small Molecule Discovery

Demo: Small Molecule Discovery in Dotmatics

Small Molecule Standard Demo Webinar

Press O for more options

Video Thumbnail

Video Thumbnail

Click for sound

32:58

Speak with a Product Expert

Request to speak with a subject matter expert so you can discover how a unified solution can address your specific needs.

Get a Demo of Dotmatics at SLAS Europe

First name

Last name

Email

Phone

CountryUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Company

Message

Comments

Request a Demo

Request a Free Demo of Dotmatics

See how a unified platform can accelerate research and help address your specific challenges.

Email

First name

Last name

Company

Phone

Job Title

CountryUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Message

Comments

Submit

Keep reading

cerevel case study thumbnailCase Study\ Unlocking Novel Targets to Treat Neuroscience Diseases at Cerevel Therapeutics

biotech pressure focusBlog\ Waiting for a Rebound: Biotechs Refocus and Run Lean

image

Get Started

Speak with one of our product experts to see how Dotmatics can enhance your current practices.

Request Demo

Biologics Discovery - prefooter right - 1